SAN DIEGO--(BUSINESS WIRE)--
Retrophin, Inc. (NASDAQ:RTRX) today announced it will report second
quarter 2015 financial results on Tuesday, August 4, 2015 after the
close of the U.S. financial markets. The Company will host a conference
call and webcast to review the financial and operational results and
provide a general business update at 4:30 p.m. ET.
|
Conference Call Information
|
|
|
|
Date:
|
|
|
|
Tuesday, August 4, 2015
|
|
Time:
|
|
|
|
4:30 p.m. ET
|
|
Dial-in numbers:
|
|
|
|
+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)
|
|
Confirmation code:
|
|
|
|
91222829
|
|
Live webcast:
|
|
|
|
www.retrophin.com
in the "Events & Presentations" section of the "Investors" page
|
A replay of the call will be available 7:30 p.m. ET, August 4, 2015 to
11:59 p.m., August 11, 2015. The replay number is 855-859-2056 (U.S.) or
404-537-3406 (International), confirmation code 91222829.
About Retrophin
Retrophin is a pharmaceutical company focused on the development,
acquisition and commercialization of drugs for the treatment of serious,
catastrophic or rare diseases for which there are currently no viable
options for patients. The Company's approved products include Chenodal®,
Cholbam™, and Thiola®, and its pipeline includes compounds for several
catastrophic diseases, including focal segmental glomerulosclerosis
(FSGS), pantothenate kinase-associated neurodegeneration (PKAN),
infantile spasms, nephrotic syndrome and others. For additional
information, please visit www.retrophin.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150721006392/en/
Retrophin, Inc.
Chris Cline, CFA
Director, Investor Relations
646-564-3680
IR@retrophin.com
Source: Retrophin, Inc.
News Provided by Acquire Media